Company intelligence / Profile preview

Spotlight Medical

Paris, Île-de-France, Francelinkedin.com ↗

Ownership: Private
Employees: ~6
Development stage: Preclinical

Overview

Spotlight Medical has developed an advanced AI-based platform that analyzes decades of patient data to generate prognosis tests aimed at optimizing cancer treatment selection. The company’s first product is set to enter clinical use soon, with the goal of reducing over/undertreatment and improving outcomes for cancer patients. Backed by leading European cancer centers and venture capital firms, it represents a new approach in precision medicine leveraging real-world data and artificial intelligence.

Therapeutic areas: Oncology
Modalities: AI-driven clinical tests/prognosis tools for cancer
Industry: Digital Health Medical Devices

Partnerships

Institut Curie (founding/backing institution)Gustave Roussy (backing institution)

Beyond the preview

Go deeper on Spotlight Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spotlight Medical.

Explore the full profile